Valiant Laboratories Intrinsic Value

VALIANTLAB • Healthcare
Current Stock Price
₹54.87
Primary Intrinsic Value
₹16.46
Market Cap
₹241.4 Cr
-60.0% Downside
Median Value
₹21.95
Value Range
₹16 - ₹106
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

VALIANTLAB Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹16.46 ₹13.17 - ₹19.75 -70.0% EPS: ₹0.16, Sector P/E: 22x
Book Value Method asset ₹106.36 ₹95.72 - ₹117.00 +93.8% Book Value/Share: ₹53.18, P/B: 2.0x
Revenue Multiple Method revenue ₹85.45 ₹76.91 - ₹94.00 +55.7% Revenue/Share: ₹42.73, P/S: 2.0x
EBITDA Multiple Method earnings ₹21.95 ₹19.75 - ₹24.14 -60.0% EBITDA: ₹4.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹21.95 ₹17.56 - ₹26.34 -60.0% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹16.46 ₹14.81 - ₹18.11 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹16.46 ₹14.81 - ₹18.11 -70.0% Revenue Growth: 6.0%, Adj P/E: 15.5x
Graham Defensive Method conservative ₹16.46 ₹14.81 - ₹18.11 -70.0% EPS: ₹0.16, BVPS: ₹53.18
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check VALIANTLAB share price latest .

Valuation Comparison Chart

VALIANTLAB Intrinsic Value Analysis

What is the intrinsic value of VALIANTLAB?

Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Valiant Laboratories (VALIANTLAB) is ₹21.95 (median value). With the current market price of ₹54.87, this represents a -60.0% variance from our estimated fair value.

The valuation range spans from ₹16.46 to ₹106.36, indicating ₹16.46 - ₹106.36.

Is VALIANTLAB undervalued or overvalued?

Based on our multi-method analysis, Valiant Laboratories (VALIANTLAB) appears to be trading above calculated value by approximately 60.0%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 1.80 Industry Standard: 2.0+ Above 1.5 Measures short-term liquidity capacity
Asset Turnover Ratio 0.47x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹1 Cr ₹-26 Cr Positive Operating Cash Flow 6/10
March 2024 ₹2 Cr ₹-70 Cr Positive Operating Cash Flow 6/10
March 2023 ₹56 Cr ₹29 Cr Positive Free Cash Flow 8/10